Literature DB >> 3893790

Atherosclerosis, calcium, and calcium antagonists.

P D Henry.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3893790     DOI: 10.1161/01.cir.72.3.456

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  9 in total

1.  Retardation of development and progression of coronary atherosclerosis: a new indication for calcium antagonists?

Authors:  W Schneider; G Kober; P Roebruck; H Noack; M Alle; G Cieslinski; N Reifart; M Kaltenbach
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 2.  Regression of coronary atherosclerosis. Angiographic perspective.

Authors:  D D Waters; J Lespérance
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 3.  Calcium antagonists: whither now?

Authors:  W G Nayler
Journal:  Cardiovasc Drugs Ther       Date:  1988-03       Impact factor: 3.727

Review 4.  Calcium antagonists--future uses.

Authors:  R Krebs
Journal:  Cardiovasc Drugs Ther       Date:  1988-03       Impact factor: 3.727

Review 5.  The potential for added benefits with beta-blockers and calcium antagonists in treating cardiovascular disorders.

Authors:  W G Nayler
Journal:  Drugs       Date:  1988       Impact factor: 9.546

6.  Effects of a high-cholesterol diet on arterial wall thickness and vascular reactivity in young rabbits.

Authors:  M Ludwig; K O Stumpe; A Sauer; R Kolloch; U Goertz; H Vetter
Journal:  Clin Investig       Date:  1992-02

Review 7.  Radiographically detectable calcium and atherosclerosis: the connection and its exploitation.

Authors:  R Detrano; S Molloi
Journal:  Int J Card Imaging       Date:  1992

8.  Effect of cyclandelate on prostacyclin release and cytosolic free calcium concentrations in human endothelial cells.

Authors:  V W van Hinsbergh
Journal:  Drugs       Date:  1987       Impact factor: 9.546

9.  Verapamil and diet halt progression of atherosclerosis in cholesterol fed rabbits.

Authors:  R E Sievers; T Rashid; J Garrett; S Blumlein; W W Parmley
Journal:  Cardiovasc Drugs Ther       Date:  1987       Impact factor: 3.727

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.